Marine Natural Products: A Source of Novel Anticancer Drugs
Open accessThe DOI matches its Crossref record; 215 of the 235 references it cites were found in a registry or an index; 37 of the 152 sources its claims cite were checked for support.
Abstract
Cancer remains one of the most lethal diseases worldwide. There is an urgent need for new drugs with novel modes of action and thus considerable research has been conducted for new anticancer drugs from natural sources, especially plants, microbes and marine organisms. Marine populations represent reservoirs of novel bioactive metabolites with diverse groups of chemical structures. This review highlights the impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals. Anti-cancer effects of marine natural products in in vitro and in vivo studies were first introduced; their activity in the prevention of tumor formation and the related compound-induced apoptosis and cytotoxicities were tackled. The possible molecular mechanisms behind the biological effects are also presented. The review highlights the diversity of marine organisms, novel chemical structures, and chemical property space. Finally, therapeutic strategies and the present use of marine-derived components, its future direction and limitations are discussed.
Overview
CoChat Summary
TL;DR
This review summarizes marine natural products as sources of novel anticancer drugs, covering marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals. It highlights cytotoxic and mechanistic findings, clinical candidates, and chemical property-space diversity, while noting that many marine compounds remain preclinical and the deep sea is largely unexplored.
Key findings
- Marine-derived compounds show anticancer activity across many tumor cell lines: cryptophycin 1 had IC50 = 0.005 and 0.003 ng/mL against KB and LOVO cells; coibamide A had LC50 < 23 nM against NCIH460 lung and mouse neuro-2a cells; salinosporamide A had IC50 = 0.13, 0.28, 7.5, and 35.0 µM against A-549, HL-60, BEL-7402, and P388 cells, respectively.
- The review reports 13 natural products isolated from marine organisms being tested in different phases of clinical trials; examples include bryostatin 1 in phase II, ET-743 in phase I, and dolastatin 10 in phase II. Marine-based drugs cited as used against leukemia, metastatic breast cancer, soft tissue sarcoma, and ovarian cancer include cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine.
- Marine biodiversity is described as vast: oceans cover over 70% of the earth, nearly 250,000 marine species are described, 99% of all bacteria cannot be cultured, and there are more than 22,000 known microbial secondary metabolites, 70% produced by actinomycetes, 20% by fungi, 7% by Bacillus spp., and 1–2% by other bacteria.
- ChemGPS-NP analysis using eight principal components based on 35 molecular descriptors showed that the reviewed marine compounds did not form tight clusters, indicating chemical diversity within classes such as marine peptides.
Methods
- Narrative review of marine natural products with anticancer activity, emphasizing marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals, and covering in vitro, in vivo, and clinical trial reports.
- For chemical property space, chemical structures were converted to SMILES using Chemsketch and submitted to ChemGPS-NPweb; eight principal component values were obtained from 35 molecular descriptors per compound, and PC1, PC2, and PC3 were plotted in three dimensions.
- Main analysis is qualitative synthesis of reported cytotoxic activities, mechanisms, and clinical status; no systematic search strategy, inclusion criteria, or quantitative meta-analysis is described.
Limitations
- Stated in the paper: sampling difficulties and the need for sufficiently large quantities for detailed analyses; less than 5% of the deep sea has been explored and less than 0.01% of the deep-sea floor sampled in detail; preclinical and clinical data for marine natural compound chemoprevention remain scant; NMR is less sensitive than MS and some compound classes cannot be detected by MS; many compounds such as calothrixins A/B, ulithiacyclamide, patellamide, borophycin, and largazole have not yet entered clinical trials; the exact mechanism of sansalvamide A is unknown.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, formal inclusion/exclusion criteria, risk-of-bias assessment, and quantitative pooling, so the findings are illustrative rather than exhaustive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
32 Valid · 3 Not valid · 64 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Advanced technology and extensive research on marine natural products have led to the discovery of a new generation of anticancer drugs currently used in clinical trials [6].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Partly supportedcites [6] Ang, 2000, In vivo antimalarial activity of the beta-carboline alkaloid manzamine A, Antimicrob. Agents Chemother. sourceExperimental — accuracy not yet measured
The Abstract (page not specified) says marine-sponge manzamines had attracted interest as potential anticancer agents and inhibited cancer-cell growth. It does not say that advanced technology produced a new generation of anticancer drugs or that any were in clinical trials; this paper reports antimalarial testing in mice. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Natural bioactive molecules exhibit cytotoxic effects by attacking macromolecules expressed by cancer cells, such as those in oncogenic signal transduction pathways [16].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Supportedcites [16] Nobili, 2009, Natural compounds for cancer treatment and prevention, Pharmacol. Res. source
The Conclusions describe natural compounds with cytotoxic activity that target macromolecules in cancer cells, including compounds targeting oncogenic signal-transduction pathways. The citing sentence paraphrases that distinction. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Over the past 50 years, emerging evidence has shown that many natural products derived from plants and microbes of marine origin (Table 1), exhibit beneficial effects in the prevention and treatment of cancer, i.e., cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine are marine-based drugs used against leukemia, metastatic breast cancer, soft tissue sarcoma and ovarian cancer [20,”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 2. Nature and Cancer Chemotherapy
What the sources say
- Partly supportedcites [20] Dyshlovoy, S.A., and Honecker, F. (2018). Marine compounds and cancer: 2017 updates. Mar. Drugs, 16. sourceExperimental — accuracy not yet measured
The paper’s main text reports anticancer activity in compounds from marine algae and microbes and identifies four marine-derived drugs approved to treat cancer. It does not establish beneficial effects in cancer prevention, so the prevention portion of the claim is unsupported. (LLM, conf=0.85)
- Not matchedcites [21] (2019, August 17). Drug Bank. Available online: http://www.drugbank.ca.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The bryostatin 1 has recently entered phase II clinical trial against melanoma, non-Hodgkin’s lymphoma, renal cancer and colorectal cancer [58,59,60].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs
What the sources say
- Not checked — no full text of the sourcecites [58] Bourhill, 2017, Enzastaurin: A lesson in drug development, Crit. Rev. Oncol. Hematol. source
- Partly supportedcites [59] Wang, 2013, Marine-derived angiogenesis inhibitors for cancer therapy, Mar. Drugs sourceExperimental — accuracy not yet measured
Section 4.1 reports phase I and II bryostatin-1 trials involving all four named cancers, and the References list phase II studies for each, including colorectal cancer (ref. 132). But the paper says more than 80 phase I and II trials had been conducted since 1993; it does not support the claim that bryostatin-1 had recently entered phase II trials. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [60] Ritchie, 2015, Cancer research UK centre for drug development: Translating 21st-century science into the cancer medicines of tomorrow, Drug Discov. Today source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Based on modern research, cultured benthic cyanobacteria from temperate marine environments provide a promising, under-exploited source for novel drugs against leukemia [107].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
What the sources say
- Could not verifycites [107] Peng, 2010, Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum, J. Am. Chem. Soc. sourceExperimental — accuracy not yet measured
The Abstract describes karlotoxin-2 from the marine dinoflagellate Karlodinium veneficum and its toxicity to fish. Searches for benthic cyanobacteria and leukemia found no passage addressing their potential as a source of leukemia drugs. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Could not verify
69 more claims · 15 with their cited sources checked
Create a free account to see all 110 claims and to verify the 12 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against KB cells and 5 µg/mL against LOVO cells (colon cancer)”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against human epidermoid carcinoma (LOVO) and human colorectal adenocarcinoma (KB) cell lines”
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“In 2018, approximately 18 million new cases of cancer reported globally, resulting in approximately 10 million deaths [1].”
BackgroundCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Prokaryotes: The unseen majority
Whitman, W. B., Coleman, D. C., & Wiebe, W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6578 · Cited by 4,871
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687 · cited 2×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundBioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170 · cited 1×
“Of these actinomycete-derived compounds, 75% were derived from Streptomyce whereas 25% were derived from rare actinomycetes [125,126].”
BackgroundNatural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · cited 1×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundMedicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391 · cited 1×
“The incidence of cancer continues to increase due to environmental changes and life style modernization [3].”
BackgroundShahidi, F., Janitha, P. K., & Wanasundara, P. D. (1992) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399209527581 · Cited by 2,238
Research works printed but not linked: 7
- Whitman, 1998, The unseen majority, Proc. Natl. Acad. Sci. USA, 74, 5088
- Reyes, 2002, The marine pharmacy: New antitumoral compounds from the sea, Pharm. News, 9, 495
- Laatsch, H. (2011). AntiBase 2011: The Natural Compound Identifier, Wiley-Vch.
- Harmon, 2000, Ecteinascidin-743 (et-743) induces objective responses and disease control in patients with advanced non-osseous sarcomas: Results from phase Ii trials, Ann. Oncol., 11, 126
- Lavakumar, 2012, Anticancer and antioxidant effect of Acanthophora spicifera against EAC induced carcinoma in mice, J. Pharm. Res., 5, 1503
- Suja, 2014, Anticancer activity of compounds isolated from marine endophytic fungus Aspergillus terreus, World J. Pharm. Pharm. Sci., 3, 661
- Devi, 2015, Molecular modeling, quantitative structure activity relationship and pharmacophore studies on antiǧviral, antiǧmalarial and antiǧinflammatory bioactive compounds from marine sources, Asian J. Pharm. Clin. Res., 8, 36
Cited by
Items 101–200 of 551
Vilakazi, H., Olasehinde, T. A., & Olaniran, A. O. (2021) · Molecules · doi:10.3390/molecules26144109 · Cited by 35
Rabiee, N., Ahmadi, S., Iravani, S., & Varma, R. S. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114803 · Cited by 29
Viswanathan, S., Palaniyandi, T., Rajeshkumar, S., et al. (2021) · Particulate Science And Technology · doi:10.1080/02726351.2021.1992059 · Cited by 28
“In recent years, searching for anti-cancer drug candidates from marine resources is increasing due to their decreased side effects (Khalifa et al. 2019).”
BackgroundYan, S.-K., Zhang, B., Feng, J., Wu, H., Duan, N., Zhu, Y., Zhao, Y., Shen, S., Zhang, K., Wu, W., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.764699 · Cited by 29
“Recently, marine natural products (MNPs) have been valuable sources for novel drug discovery due to their unique chemical diversity and excellent biological activity (Khalifa et al., 2019).”
BackgroundNanomedicine Based on Natural Products: Improving Clinical Application Potential
Li, Z., Zhao, T., Li, J., Yu, Q., Feng, Y., Xie, Y., & Sun, P. (2022) · Journal of Nanomaterials · doi:10.1155/2022/3066613 · Cited by 32
“In the late 1980s, improved science, technology, and modern bioengineering, individuals began to pay more attention to marine organisms [16].”
BackgroundIndispensable role of microbes in anticancer drugs and discovery trends
Kapoor, R., Saini, A., & Sharma, D. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12046-2 · Cited by 31
Touliabah, H. E.-S., El-Sheekh, M. M., & Makhlof, M. E. M. (2022) · Frontiers in Marine Science · doi:10.3389/fmars.2022.1092343 · Cited by 27
Bioactive and unusual steroids from Penicillium fungi
Lindsay, C. A., Kinghorn, A. D., & Harinantenaina, L. (2023) · Phytochemistry · doi:10.1016/j.phytochem.2023.113638 · Cited by 37
Bioactivity Screening and Gene-Trait Matching across Marine Sponge-Associated Bacteria
Gavriilidou, A., Mackenzie, T. A., Sánchez, P., Tormo, J. R., Ingham, C. J., Smidt, H., & Sipkema, D. (2021) · Marine Drugs · doi:10.3390/md19020075 · Cited by 27
Bansal, P., Kumar, R., Singh, J., et al. (2021) · Journal of Proteins and Proteomics · doi:10.1007/s42485-021-00072-z · Cited by 26
El-Seedi, H. R., El-Mallah, M. F., Yosri, N., Alajlani, M. M., Zhao, C., Mehmood, M. A., Du, M., Ullah, H., Daglia, M., Guo, Z., et al. (2023) · Marine Drugs · doi:10.3390/md21080439 · Cited by 29
Self-citationZare, A., Ablakimova, N., Kaliyev, A. A., Mussin, N. M., Tanideh, N., Rahmanifar, F., & Tamadon, A. (2024) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2024.116751 · Cited by 33
Hernández, I., Rodeiro, I., Declerck, K., Herrera, J., Perez-Novo, C. A., Camp, G. V., Wever, O. D., González, K., Labrada, M., Carr, A., et al. (2021) · Marine Drugs · doi:10.3390/md19020052 · Cited by 26
“The discovery and development of marine drugs against cancer has been extremely rewarding with significant scientific gains, such as the discovery of new anticancer mechanisms of action as well as novel molecular targets [28,29].”
BackgroundKonstantinou, E. K., Panagiotopoulos, A. A., Argyri, K., Panoutsopoulos, G. I., Dimitriou, M., & Gioxari, A. (2023) · Nutrients · doi:10.3390/nu16010002 · Cited by 32
“…plant-derived cytotoxic natural products studied for further improvement and development of drugs, such as phenolic acids, flavonoids, tannins, coumarins, lignans, lignins, naphtoquinones, anthraquinones, xanthones, and stilbenes, which are well-known phenolic compounds found in plant taxa [67,68].”
BackgroundAnticancer potential of nanoformulated extract of Passiflora incarnata leaves
Deepika, B., Pallavi, P., Gowtham, P., et al. (2024) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2024.103109 · Cited by 25
Recent Advances in Marine-Derived Bioactives Towards Cancer Therapy
Tamzi, N. N., Rahman, M. M., & Das, S. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4040051 · Cited by 46
“Marine-derived bioactives are thought to have increased bioactivity and bioavailability, offering significant potential for the development of novel anticancer agents [53–55].”
Hongwiangchan, N., Sriratanasak, N., Wichadakul, D., Aksorn, N., Chamni, S., & Chanvorachote, P. (2021) · Pharmaceuticals · doi:10.3390/ph14111112 · Cited by 29
“Natural marine compounds and their synthetic derivatives have been investigated in clinical trials [17].”
BackgroundTherapeutic potential of marine peptides in cervical and ovarian cancers
Ahmed, S., Khan, H. Z., Fakhri, S., Aschner, M., & Cheang, W. S. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04306-y · Cited by 24
Physiological and Clinical Aspects of Bioactive Peptides from Marine Animals
Chakniramol, S., Wierschem, A., Cho, M.-G., & Bashir, K. M. I. (2022) · Antioxidants · doi:10.3390/antiox11051021 · Cited by 24
“Recent research has claimed that anticancer compounds from marine sources, especially marine natural bioactive products [58] and nanomaterials, as a safer alternative, allowing targeted treatment to cancer cells and not inducing damage to the healthy cells [59,60].”
BackgroundSaudi Arabian Plants: A Powerful Weapon against a Plethora of Diseases
El-Seedi, H. R., Kotb, S. M., Musharraf, S. G., Shehata, A. A., Guo, Z., Alsharif, S. M., Saeed, A., Hamdi, O. A. A., Tahir, H. E., Alnefaie, R., et al. (2022) · Plants · doi:10.3390/plants11243436 · Cited by 25
“3 million new cancer cases and nearly 10 million deaths from cancer worldwide in 2020 [82,83].”
Self-citationNew Cytotoxic Natural Products from the Red Sea Sponge Stylissa carteri
Abdelhameed, R. F. A., Habib, E. S., Eltahawy, N. A., et al. (2020) · Marine Drugs · doi:10.3390/md18050241 · Cited by 24
Assessing the diversity of bacterial communities from marine sponges and their bioactive compounds
Bibi, F., Naseer, M. I., & Azhar, E. I. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.03.042 · Cited by 26
“Marine Halomonas have been described as a source of bioactive metabolites and surfactants (Khalifa et al., 2019; Arahal and Ventosa, 2006).”
BackgroundZhu, W., Wang, S., Gao, H., Ge, Y., Dai, J., Zhang, X., & Yang, Q. (2021) · Marine Drugs · doi:10.3390/md20010034 · Cited by 25
Marine-derived Natural Products as Anticancer Agents
Saini, N., Sirohi, R., Anuradha, A., Saini, N., Wadhwa, P. K., Kaur, P., Sharma, V., Singh, G., Singh, I., & Sahu, S. K. (2022) · Medicinal Chemistry · doi:10.2174/1573406419666221202144044 · Cited by 23
Uras, İ. S., Karslı, B., Konuklugil, B., Öçsoy, İ., & Demırbas, A. (2023) · Sustainability · doi:10.3390/su15054638 · Cited by 23
Chamni, S., Sirimangkalakitti, N., Pithi Chanvorachote, B., Suwanborirux, K., & Saito, N. (2020) · Marine Drugs · doi:10.3390/md18080418 · Cited by 26
“Several marine compounds and their synthetic derivatives are currently being investigated in different clinical trials [5,6].”
BackgroundAntiviral and Antiproliferative Potential of Marine Organisms From the Yucatan Peninsula, Mexico
Pech-Puch, D., Berastegui‐Cabrera, J., Pérez-Povedano, M., Villegas‐Hernández, H., Guillén-Hernández, S., Cautain, B., Reyes, F., Pachón, J., Gómez, P., Rodríguez, J., et al. (2020) · Frontiers in Marine Science · doi:10.3389/fmars.2020.00607 · Cited by 22
Marine Algae as a Potential Source for Anti-diabetic Compounds - A Brief Review
Rayapu, L., Chakraborty, K., & Valluru, L. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200909124526 · Cited by 24
Indole diketopiperazine alkaloids from the deep-sea-derived fungus Aspergillus sp. FS445
Liu, Z., Chen, Y., Li, S., et al. (2021) · Natural Product Research · doi:10.1080/14786419.2021.1925271 · Cited by 23
“In addition, it has been proved that the marine-derived fungi are a promising source for the discovery of novel biological active agents during the past two decades such as anticancer, antiinflammatory and antitubercular (Hou et al. 2019; Khalifa et al. 2019; Xu et al. 2019).”
BackgroundFerdous, U. T., Nurdin, A., Ismail, S., Shaari, K., & Yusof, Z. N. B. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2024.100456 · Cited by 29
Advanced Technologies for Large Scale Supply of Marine Drugs
Martínez, H., Santos, M., Pedraza, L., & Testera, A. M. (2025) · Marine Drugs · doi:10.3390/md23020069 · Cited by 29
Marine-Derived Biologically Active Compounds for the Potential Treatment of Rheumatoid Arthritis
Bilal, M., Qindeel, M., Nunes, L. V., Duarte, M. T. S., Ferreira, L. F. R., Soriano, R. N., & Iqbal, H. M. N. (2020) · Marine Drugs · doi:10.3390/md19010010 · Cited by 27
González-Ballesteros, N., Flórez-Fernández, N., Torres, M. D., Domínguez, H., & Rodríguez-Argüelles, M. C. (2021) · Algal Research · doi:10.1016/j.algal.2021.102377 · Cited by 23
Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications
Veríssimo, A. C. S., Pacheco, M., Silva, A. M. S., & Pinto, D. C. G. A. (2021) · Molecules · doi:10.3390/molecules26144292 · Cited by 25
“Synthesis of these marine natural products may be associated with the need on the part of these organisms to produce secondary metabolites as a defense tool to survive in extreme environments, such as temperature, salinity, pressure, and predators [21].”
BackgroundChen, J., Hu, Y., Zhang, J., Wang, Q., Wu, X.-Z., Huang, W., Wang, Q., Cai, G., Wang, H., Ou, T., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106160 · Cited by 23
Hernández‐Zazueta, M. S., Luzardo‐Ocampo, I., García‐Romo, J. S., Noguera‐Artiaga, L., Carbonell-Barrachina, Á. A., Taboada, P., Campos-Vega, R., Rosas‐Burgos, E. C., Burboa‐Zazueta, M. G., Ezquerra‐Brauer, J. M., et al. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112119 · Cited by 27
Malhão, F., Macedo, A. C., Costa, C., Rocha, E., & Ramos, A. A. (2021) · Molecules · doi:10.3390/molecules26144288 · Cited by 24
“Marine organisms yield a wide variety of bioactive compounds with unique properties and promising potential for developing new anticancer drugs [6,7].”
BackgroundMalyarenko, O. S., Malyarenko, T. V., Usoltseva, R. V., Silchenko, A. S., Kicha, A. A., Ivanchina, N. V., & Ermakova, S. P. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.080 · Cited by 22
Lu, I., Lin, S., Chu, Y.-C., Wen, Y., Lin, Y.-C., Cheng, W., Sheu, J., & Lin, C. (2022) · Marine Drugs · doi:10.3390/md20020109 · Cited by 23
“Bioactive compounds derived from natural products are promising candidates for cancer drug development [5,6].”
BackgroundAnticancer Potential of Thymoquinone: A Novel Bioactive Natural Compound from Nigella sativa L.
Mir, P. A., Mohi-ud-din, R., Banday, N., Maqbool, M., Raza, S. N., Farooq, S., Afzal, S., & Mir, R. H. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220511233314 · Cited by 23
Shen, Y., Sheng, R., & Guo, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060827 · Cited by 20
Xue, Y., Fu, Y., Zhao, F., Gui, G., Li, Y., Rivero-Hinojosa, S., Liu, G., Li, Y.-Q., Xia, S., Eberhart, C. G., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0603 · Cited by 20
“Some natural compounds from marine sources have shown therapeutic efficacy in preclinical cancer models (18).”
BackgroundOpportunities for Microbiome Suppression of Weeds Using Regenerative Agricultural Technologies
Cheng, L., DiTommaso, A., & Kao‐Kniffin, J. (2022) · Frontiers in Soil Science · doi:10.3389/fsoil.2022.838595 · Cited by 26
“Sample collection was expanded to sources beyond soils; for example, some anti-cancer compounds were successfully derived from marine samples (50).”
BackgroundMarine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options
Ahmed, S., Alam, W., Aschner, M., Filosa, R., Cheang, W. S., Jeandet, P., Saso, L., & Khan, H. Z. (2023) · Cancers · doi:10.3390/cancers15092515 · Cited by 23
Visuddho, V., Halim, P., Helen, H., Muhar, A. M., Iqhrammullah, M., Mayulu, N., Surya, R., Tjandrawinata, R. R., Ribeiro, R. I. M. D. A., Tallei, T. E., et al. (2024) · Marine Drugs · doi:10.3390/md22080338 · Cited by 24
Novel molecules as the emerging trends in cancer treatment: an update
Sekar, P., Ravitchandirane, R., Khanam, S., Muniraj, N., & Cassinadane, A. V. (2022) · Medical Oncology · doi:10.1007/s12032-021-01615-6 · Cited by 21
“This study is still going on, and it’s using cutting-edge technology [14].”
BackgroundShi, Y., Sun, X., Zhang, J., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c03959 · Cited by 19
Exploring the secrets of marine microorganisms: Unveiling secondary metabolites through metagenomics
Wang, S., Li, X., Yang, W., & Huang, R. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.14533 · Cited by 18
“Research in this area has already identified potential anticancer drugs and other bioactive substances in marine organisms, marking significant progress in medicine and biotechnology (Khalifa et al., 2019; Martins et al., 2014).”
BackgroundHossain, M. T., Sohag, A. A. M., Haque, M. N., Tahjib‐Ul‐Arif, M., Dash, R., Chowdhury, M. T. H., Hossain, M. A., Moon, I. S., & Hannan, M. A. (2021) · Journal of Aquatic Food Product Technology · doi:10.1080/10498850.2020.1869876 · Cited by 21
Alhadrami, H. A., Alkhatabi, H. A., Abduljabbar, F. H., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111846 · Cited by 19
“Anticancer properties against many cancer types are the most frequently reported bioactivities of softcoral-derived natural products [13].”
BackgroundNewehy, A. S. E., Gheda, S. F., Ismail, M. M., Aldisi, D. A., Abulmeaty, M. M. A., & Elshobary, M. E. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070826 · Cited by 25
A deep dive into genome assemblies of non-vertebrate animals
Guiglielmoni, N., Rivera‐Vicéns, R. E., Koszul, R., & Flot, J. (2022) · Peer Community Journal · doi:10.24072/pcjournal.128 · Cited by 17
Zayed, M., El‐Garawani, I. M., El-Sabbagh, S. M., Amr, B., Alsharif, S. M., Tayel, A. A., Alajmi, M. F., Ibrahim, H. M. S., Shou, Q., Khalifa, S. A. M., et al. (2022) · Metabolites · doi:10.3390/metabo12111102 · Cited by 21
Self-citationMarine-Originated Materials and Their Potential Use in Biomedicine
Lаgopati, N., Pippa, Ν., Gatou, Μ.-A., Papadopoulou-Fermeli, N., Gorgoulis, V. G., Gazouli, M., & Pavlatou, E. A. (2023) · Applied Sciences · doi:10.3390/app13169172 · Cited by 20
A review on Persian Gulf brown algae as potential source for anticancer drugs
Sadeghi, A., Rajabiyan, A., Nezhad, N. M., Nabizade, N., Alvani, A., & Ahmady, A. Z. (2024) · Algal Research · doi:10.1016/j.algal.2024.103446 · Cited by 20
Huang, T.-Y., Huang, C.-Y., Chen, S.-R., Weng, J.-R., Tu, T.-H., Cheng, Y.-B., Wu, S.-H., & Sheu, J. (2020) · Marine Drugs · doi:10.3390/md19010008 · Cited by 17
Marine Fungi: A Prosperous Source of Novel Bioactive Natural Products
Ji, R., Zha, X., & Zhou, S. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673266304231015070956 · Cited by 17
Bioactive Properties of Peptides and Polysaccharides Derived from Peanut Worms: A Review
Qi, Y., Zhou, J., Shen, X., Chalamaiah, M., Lv, S., Luo, H., & Liang, C. (2021) · Marine Drugs · doi:10.3390/md20010010 · Cited by 23
Singh, N., Tapader, R., Chatterjee, S., Pal, A., & Pal, A. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.086 · Cited by 16
Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies
Fernandes, A. M., Oliveira, C., Reis, R. L., Martins, A. M., & Silva, T. H. (2022) · Marine Drugs · doi:10.3390/md20110689 · Cited by 23
Palomo, A. O., Quiñonero, F., Ortíz, R., Sarabia, F., Prados, J. C., & Melguizo, C. (2024) · Marine Drugs · doi:10.3390/md22030101 · Cited by 20
“Roughly 80% of approved chemotherapeutic drugs and over half of all pharmaceuticals are derived from bioactive natural products [6].”
BackgroundNova, M., Citterio, S., Martegani, E., & Colombo, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084215 · Cited by 18
“In recent years, marine natural products have become one of the most important sources of new compounds potentially useful in the treatment of age-related diseases, such as cancer, neurodegenerative and cardiovascular diseases, metabolic syndrome and many others [2–5].”
BackgroundSeagrass Meadows: Prospective Candidates for Bioactive Molecules
Ameen, H. M., Jayadev, A., Prasad, G., & Nair, D. I. (2024) · Molecules · doi:10.3390/molecules29194596 · Cited by 24
“…applications for seagrasses can incentivize their protection and restoration, enhancing the Such compounds may possess anti-in fl ammatory, antimicrobial, anticancerous, or antioxidant activities, o ff ering potential bene fi ts for human health [30–34]. wellness and durability of coastal ecosystems.”
BackgroundWu, Y., Wei, W., Dai, G.-F., Su, J., Tseng, Y.-H., & Tsai, T. (2020) · Marine Drugs · doi:10.3390/md18060314 · Cited by 17
“Marine-based drugs to combat cancer and other diseases have been developed and introduced in clinical settings [10,11].”
BackgroundRodrigo, A. P., Mendes, V. M., Manadas, B. J., Grosso, A. R., Matos, A., Baptista, P. V., Costa, P. M., & Fernandes, A. R. (2021) · Marine Drugs · doi:10.3390/md19010031 · Cited by 17
“Accordingly, there is growing interest in the search for novel anti-cancer compounds in marine life, benefitting from the constant advances in omics methods from metabolomics to proteomics and transcriptomics [11].”
BackgroundDiscovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis
Khan, S., Al-Fadhli, A. A., & Tilvi, S. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113491 · Cited by 19
Anti-Candidal Marine Natural Products: A Review
Arumugam, G., Gonçale, J. C., Rajaram, R., & Junqueira, J. C. (2023) · Journal of Fungi · doi:10.3390/jof9080800 · Cited by 24
“For example, more than 30,000 chemical compounds were reported from the marine environment with anticancer properties [14,15].”
BackgroundYu, Y., Bu, F.-Z., Meng, S.-S., Yan, C., Wu, Z., & Li, Y. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123300 · Cited by 18
Xiao, W., Xu, Y., Baak, J. P. A., Dai, J., Jing, L., Zhu, H., Gan, Y., & Zheng, S. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04148-9 · Cited by 21
“The rapid development of resistance to anticancer agents and their unwanted side effects increase the demand for novel anti-tumor drugs that can become active against untreatable cancers [18].”
BackgroundVenkatachalam, J., Jeyadoss, V. S., Bose, K. S. C., & Subramanian, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09511-8 · Cited by 16
Marasinghe, C. K., Yoon, S., & Je, J. (2024) · BioFactors · doi:10.1002/biof.2075 · Cited by 23
Ha, Y. N., Song, S., Orlikova-Boyer, B., Cerella, C., Christov, C., Kijjoa, A., & Diederich, M. F. (2020) · Marine Drugs · doi:10.3390/md18010057 · Cited by 16
“However, unlike many terrestrial natural compounds such as taxol, obtained from the Western Pacific yew tree Taxus brevifolia, marine natural compounds remain less investigated [21].”
BackgroundOxygenated Cembrene Diterpenes from Sarcophyton convolutum: Cytotoxic Sarcoconvolutum A–E
Mohamed, T. A., Elshamy, A. I., Abdel-Tawab, A. M., et al. (2021) · Marine Drugs · doi:10.3390/md19090519 · Cited by 16
Self-citation3-D Culture of Marine Sponge Cells for Production of Bioactive Compounds
Urban‐Gedamke, E., Conkling, M., McCarthy, P. J., Wills, P. S., & Pomponi, S. A. (2021) · Marine Drugs · doi:10.3390/md19100569 · Cited by 21
“Unfortunately, many pharmaceutically relevant MNPs are found only in trace amounts within the source sponge [2,3], and it is neither economically nor ecologically feasible to harvest enough wild sponge biomass to supply the necessary quantities for clinical drug development and manufacture [3].”
Magalhães, R., Mil-Homens, D., Cruz, S., & Oliveira, M. (2025) · Antibiotics · doi:10.3390/antibiotics14080808 · Cited by 19
“Most marine AMPs tolerate high salinity, pressure, and drastic fluctuations in pH, nutrient availability, oxygen levels and temperature, reflecting the highly competitive and demanding nature of their environment, contrary to their terrestrial and freshwater counterparts [1,12,34,37,38].”
Cyanobacteria derived compounds: Emerging drugs for cancer management
Shahid, A., Khurshid, M., Aslam, B., Muzammil, S., Mehwish, H. M., Rajoka, M. S. R., Hayat, H. F., Sarfraz, M. H., Razzaq, M. K., Nisar, M. A., et al. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202100459 · Cited by 19
Marasinghe, C. K., Jung, W., & Je, J. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14493 · Cited by 15
Eydelkhani, M., Kiabi, S., & Nowruzi, B. (2024) · BMC Biotechnology · doi:10.1186/s12896-024-00855-4 · Cited by 20
Therapeutic potential of marine peptides in glioblastoma: Mechanistic insights
Ahmed, S., Hasan, M. M., Aschner, M., Mirzaei, H., Alam, W., Shah, S. M. M., & Khan, H. Z. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110142 · Cited by 16
Potential Prebiotic and Anti-Obesity Effects of Codium fragile Extract
Oh, S. W., Kim, S., Jung, K.-J., Pham, T. N. A., Yang, S. H., & Ahn, B.-J. (2022) · Applied Sciences · doi:10.3390/app12030959 · Cited by 12
Anti-inflammatory, anti-infectious and anti-cancer potential of marine algae and sponge: A review
Naqvi, S. A. R., Sherazi, T. A., Hassan, S. U., Shahzad, S. A., & Faheem, Z. (2022) · European Journal of Inflammation · doi:10.1177/20587392221075514 · Cited by 21
Zhao, H.-M., He, J., Chang, Y., et al. (2022) · Journal of Natural Products · doi:10.1021/acs.jnatprod.2c00673 · Cited by 14
Rawal, R., Gupta, P. K., Kumar, B., et al. (2023) · Assay and Drug Development Technologies · doi:10.1089/adt.2022.085 · Cited by 14
Garlic‐derived compounds: Epigenetic modulators and their antitumor effects
Zhang, H., Wang, H., Qin, L., & Lin, S. (2024) · Phytotherapy Research · doi:10.1002/ptr.8108 · Cited by 16
“About 80% of the approved chemotherapy drugs are natural products with biological activity And 87% of human diseases, including cancer, are treated with natural products (Khalifa et al., 2019; Newman & Cragg, 2012, 2016).”
BackgroundUnlocking the Therapeutic Potential of Algae-Derived Compounds in Hematological Malignancies
Vujović, T., Paradžik, T., Babić, S., & Piva, R. (2025) · Cancers · doi:10.3390/cancers17020318 · Cited by 18
Encouraging Leads from Marine Sources for Cancer Therapy A Review Approach
Srinivasan, N., Dhanalakshmi, S. R., & Pandian, P. (2020) · Pharmacognosy Journal · doi:10.5530/pj.2020.12.202 · Cited by 15
Toxicity Bioassay and Cytotoxic Effects of the Benthic Marine Dinoflagellate Amphidinium operculatum
Mejía-Camacho, A. L., Durán-Riveroll, L. M., & Cembella, A. D. (2021) · Journal of Xenobiotics · doi:10.3390/jox11020003 · Cited by 15
“A few of these novel therapeutants are in the final phases of clinical trials or in preliminary market phase, indicating high promise for dinoflagellate-derived metabolites as anticancer agents [4,30].”
BackgroundLiu, Y., Li, Y., Chen, M., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108931 · Cited by 14
Jo, M.-H., Kim, Y.-T., & Park, S. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214149 · Cited by 18
“Many efforts have been made to find anticancer components from marine algae, because marine environments provide biodiversity and an excellent source of bioactive compounds [17,18].”
BackgroundIksen, I., Sinsook, S., Wattanathamsan, O., Buaban, K., Chamni, S., & Pongrakhananon, V. (2022) · Molecules · doi:10.3390/molecules27248948 · Cited by 18
“Growing evidence has demonstrated th t marine ecosys ems are versatile resources for th discovery of novel antic cer medications [6,7].”
BackgroundDai, L., Tian, S., Zhang, J., Lu, M., Zhu, J., & Zhao, H. (2021) · BioMed Research International · doi:10.1155/2021/6650045 · Cited by 14
“A variety of natural products have entered the market or clinical research stage of cancer treatment, and research on the mechanisms is also increasing [7].”
BackgroundThe potential of marine-based gold nanomaterials in cancer therapy: a mini-review
Baghban, N., Khoradmehr, A., Nabipour, I., Tamadon, A., & Ullah, M. (2022) · Gold bulletin · doi:10.1007/s13404-021-00304-6 · Cited by 12
“The results of scientific studies on the medicinal properties of these products are promising for treating many diseases, including cancer, and are also able to reduce the toxicity of other drugs due to their antioxidant properties [59, 132].”
BackgroundMolla, M. H. R., & Aljahdali, M. O. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103748 · Cited by 15
“The pharmacophore diversity has been growing for the last few decades, but still, natural products from the Red Sea are not being discovered properly (Khalifa et al., 2019).”
BackgroundIndoloquinazoline alkaloids suppress angiogenesis and inhibit metastasis of melanoma cells
Guo, X., Fan, A., Qi, X., Liu, D., Huang, J., & Lin, W. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106873 · Cited by 13
Kang, N., Heo, S., Kim, E.-A. L., Cha, S., Ryu, B., & Heo, S. (2023) · ALGAE · doi:10.4490/algae.2023.38.11.29 · Cited by 13
Plant Disease Management by Bioactive Natural Products
Singh, S., Kumar, V., Datta, S., Dhanjal, D. S., & Singh, J. (2020) · Springer eBooks · doi:10.1007/978-981-15-3024-1_2 · Cited by 19
Anti-lung Cancer Marine Compounds: A Review
Miri, M. R., Zare, A., Saberzadeh, J., Baghban, N., Nabipour, I., & Tamadon, A. (2022) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-022-00375-3 · Cited by 14
“In addition, the rapid development of resistance to anticancer agents and their unwanted side effects increase the demand for novel antitumor drugs that can become active against untreatable cancers [3].”
BackgroundXu, J., Chen, Y., Liu, Z., et al. (2021) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202000621 · Cited by 13
Fucoidan in cancer therapy: from biomedical application to medicinal chemistry approach
Zheng, Y., Fang, S., Liu, N., Zhang, T., Huang, Y., Li, L., Tian, Y. P., Hu, X., Ji, Y., Guo, Y., et al. (2025) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-025-06962-8 · Cited by 14
“Many successful projects in drug development and medicinal chemistry have concentrated on natural compounds uncovered in the ocean [5].”
Suleiman, S., Fiore, R. D., Cassar, A., Formosa, M. M., Schembri-Wismayer, P., & Calleja‐Agius, J. (2020) · Tumor Biology · doi:10.1177/1010428320954735 · Cited by 15
Metadata
- Authors
- Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., Chang, F.-R., Iwasaki, A., Suenaga, K., Alajlani, M., Göransson, U., & El-Seedi, H. R.
- Affiliations
- Karolinska University Hospital (SE)
- University of Kalamoon (SY)
- Cairo University (EG)
- Fujian Agriculture and Forestry University (CN)
- Quaid-i-Azam University (PK)
- Johannes Gutenberg University Mainz (DE)
- Kuwait University (KW)
- Department of Chemistry, Faculty of Science, University of Kuwait, 13060 Safat, Kuwait
- University of Karachi (PK)
- Kaohsiung Medical University (TW)
- Keio University (JP)
- Uppsala University (SE)
- Jiangsu University (CN)
- Corresponding author
- El-Seedi, Hesham R.
- ORCID
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 17
- Issue
- 9
- Pages
- 491
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6780632
- OpenAlex
- W2969876208
- Semantic Scholar
- fc04613de468c55e3c00acaa04bbf85967f96088
- Cited by
- 555
- References
- 235
- Citations by year
- 2026: 32 · 2025: 73 · 2024: 100 · 2023: 88 · 2022: 109 · 2021: 98 · 2020: 49 · 2019: 4
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Uppsala University (Swedish Research links grant 2016-05885 (VR for the years 2017 - 2019))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- marine natural products, anticancer agents, marine organisms, marine algae, marine bacteria, actinomycetes, marine fungi, marine sponges, soft coral, marine plants, apoptosis, cytotoxicity, cancer prevention, molecular mechanisms, bioactive metabolites, anticancer drug discovery
- MeSH terms
- Animals, Antineoplastic Agents, Biological Products, Clinical Trials as Topic, Disease Models, Animal, Humans, Neoplasms, Treatment Outcome, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.